Severe Mitral Regurgitation, an Unusual Manifestation of Chemotherapy-Induced Cardiotoxicity

Severe Mitral Regurgitation, an Unusual Manifestation of Chemotherapy-Induced Cardiotoxicity Publisher

Mirdamadi A¹ ; Naeini AE² ; Behjati M³

Show Affiliations

1. Department of Cardiology, Najafabad Branch, Islamic Azad University, Isfahan, Iran
2. Department of Nephrology, Isfahan Kidney Diseases Research Centre, Isfahan University of Medical Sciences, Isfahan, Iran
3. Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran

Source: Journal of Research in Medical Sciences Published:2017

Abstract

Cardiotoxicity is one of the most feared side effects of chemotherapy with enhanced morbidity and mortality in survivors. Arrhythmia, heart failure, myocardial ischemia, hypertension, and thromboembolism are commonly reported as side effects. Hereby, we are reporting a case of severe mitral regurgitation as a complication of chemotherapy. © 2017 Journal of Research in Medical Sciences.

Related Docs

View other Related Docs

1. Ac-Mode of Chemotherapy As a Trigger of Cardiac Syndrome X: A Case Study, Current Problems in Cardiology (2022)

2. Comparison of Cardioprotective Effects of Dapagliflozin and Trimetazidine in the Model of Doxorubicin-Cyclophosphamide Cardiotoxicity; [Сравнительная Характеристика Кардиопротекторных Эффектов Дапаглифлозина И Триметазидина На Модели Доксорубицин-Циклофосфамидной Кардиотоксичности], Innovative Medicine of Kuban (2023)

3. Prevalence of Major Cardiac Events of Anthracycline-Induced Cardiotoxicity in Southwestern Iran: Different Response Patterns to Cumulative Dose, Current Drug Therapy (2020)

4. Alterations in the Echocardiographic Variables of the Right Ventricle in Asymptomatic Patients With Breast Cancer During Anthracycline Chemotherapy, Postgraduate Medical Journal (2017)

5. Anthracycline Associated Disturbances of Cardiovascular Homeostasis, Current Problems in Cardiology (2022)

6. Trimetazidine As a Modifier of Chemotherapy-Induced Cardiovascular Redox-Homeostasis Disturbances, Kardiologija v Belarusi (2022)

7. Evaluation of Expression Level of Mir-3135B-5P in Blood Samples of Breast Cancer Patients Experiencing Chemotherapy-Induced Cardiotoxicity, Indian Journal of Clinical Biochemistry (2023)

8. Doxorubicin and Cyclophosphamide Mode of Chemotherapy-Related Cardiomyopathy: Review of Preclinical Model, Current problems in cardiology (2025)

Experts (# of related papers)

View all Related Experts

Nizal Sarrafzadegan (4)

Golnaz Vaseghi (2)

Style	Citing Format
MLA	Mirdamadi A, Naeini AE, Behjati M. "Severe Mitral Regurgitation, an Unusual Manifestation of Chemotherapy-Induced Cardiotoxicity." Journal of Research in Medical Sciences, vol. 22, no. 12, 2017, pp. -.
APA	Mirdamadi A, Naeini AE, Behjati M (2017). Severe Mitral Regurgitation, an Unusual Manifestation of Chemotherapy-Induced Cardiotoxicity. Journal of Research in Medical Sciences, 22(12), -.
Chicago	Mirdamadi A, Naeini AE, Behjati M. "Severe Mitral Regurgitation, an Unusual Manifestation of Chemotherapy-Induced Cardiotoxicity." Journal of Research in Medical Sciences 22, no. 12 (2017): -.
Harvard	Mirdamadi A, Naeini AE, Behjati M (2017) 'Severe Mitral Regurgitation, an Unusual Manifestation of Chemotherapy-Induced Cardiotoxicity', Journal of Research in Medical Sciences, 22(12), pp. -.
Vancouver	Mirdamadi A, Naeini AE, Behjati M. Severe Mitral Regurgitation, an Unusual Manifestation of Chemotherapy-Induced Cardiotoxicity. Journal of Research in Medical Sciences. 2017;22(12):-.
BibTex	@article{ author = {Mirdamadi A and Naeini AE and Behjati M}, title = {Severe Mitral Regurgitation, an Unusual Manifestation of Chemotherapy-Induced Cardiotoxicity}, journal = {Journal of Research in Medical Sciences}, volume = {22}, number = {12}, pages = {-}, year = {2017} }
RIS	TY - JOUR AU - Mirdamadi A AU - Naeini AE AU - Behjati M TI - Severe Mitral Regurgitation, an Unusual Manifestation of Chemotherapy-Induced Cardiotoxicity JO - Journal of Research in Medical Sciences VL - 22 IS - 12 SP - EP - PY - 2017 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract